Islet cell function is as interesting as insulin resistance for T2DM treatment options.
Göke
Burkhard
B
Ludwig-Maximilians-University of Munich, Munich, Germany.
D000218:Adamantane / Q000031:analogs & derivatives / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000378:metabolism*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D006801:Humans; D007333:Insulin Resistance; D007515:Islets of Langerhans / Q000201:enzymology*; D009570:Nitriles / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D000077597:Vildagliptin
D054873:Dipeptidyl-Peptidase IV Inhibitors; D009570:Nitriles; D011759:Pyrrolidines; D000077597:Vildagliptin; D000218:Adamantane